Production of recombinant coagulation factors: Are humans the best host cells?
Sign Up to like & getrecommendations! Published in 2017 at "Bioengineered"
DOI: 10.1080/21655979.2017.1279767
Abstract: ABSTRACT The main treatment option for Hemophilia A/B patients involves the administration of recombinant coagulation factors on-demand or in a prophylactic approach. Despite the safety and efficacy of this replacement therapy, the development of antibodies… read more here.
Keywords: recombinant coagulation; coagulation factors; production recombinant; human cell ... See more keywords